MMP9 and intracranial hemorrhage: It has been also suggested that alteplase may promote intracranial hemorrhage through non-fibrinolytic mechanisms, such as activation of the immune system (38), neutrophil degranulation and release of matrix metalloproteinase-9 (MMP-9) (39) favoring BBB disruption (40).